Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring nanotechnology solutions for improved outcomes in gastrointestinal stromal tumors.
Gabellone S, Vanni S, Fausti V, Miserocchi G, Liverani C, Spadazzi C, Cocchi C, Calabrese C, Cavaliere D, Pacilio CA, Ercolani G, Pieri F, Gurrieri L, Riva N, Jones R, De Vita A. Gabellone S, et al. Among authors: fausti v. Heliyon. 2024 Nov 22;10(23):e40596. doi: 10.1016/j.heliyon.2024.e40596. eCollection 2024 Dec 15. Heliyon. 2024. PMID: 39687122 Free PMC article. Review.
First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax).
Ridolfi L, Gurrieri L, Riva N, Bulgarelli J, De Rosa F, Guidoboni M, Fausti V, Ranallo N, Calpona S, Tazzari M, Petrini M, Granato AM, Pancisi E, Foca F, Dall'Agata M, Bondi I, Amadori E, Cortesi P, Zani C, Ancarani V, Gamboni A, Polselli A, Pasini G, Bartolini D, Maimone G, Arpa D, Tosatto L. Ridolfi L, et al. Among authors: fausti v. Front Immunol. 2024 Aug 13;15:1404861. doi: 10.3389/fimmu.2024.1404861. eCollection 2024. Front Immunol. 2024. PMID: 39192978 Free PMC article. Clinical Trial.
Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatment.
Vanni S, Miserocchi G, Gallo G, Fausti V, Gabellone S, Liverani C, Spadazzi C, Cocchi C, Calabrese C, De Luca G, Bassi M, Gessaroli M, Tomasetti N, Campobassi A, Pieri F, Ercolani G, Cavaliere D, Gurrieri L, Riva N, Recine F, Ibrahim T, Mercatali L, Jones R, De Vita A. Vanni S, et al. Among authors: fausti v. Exp Hematol Oncol. 2024 Aug 5;13(1):74. doi: 10.1186/s40164-024-00540-4. Exp Hematol Oncol. 2024. PMID: 39103896 Free PMC article.
Clinical and translational implications of immunotherapy in sarcomas.
Recine F, Vanni S, Bongiovanni A, Fausti V, Mercatali L, Miserocchi G, Liverani C, Pieri F, Casadei R, Cavaliere D, Falbo PT, Diano D, Ibrahim T, De Vita A. Recine F, et al. Among authors: fausti v. Front Immunol. 2024 Jun 25;15:1378398. doi: 10.3389/fimmu.2024.1378398. eCollection 2024. Front Immunol. 2024. PMID: 38983859 Free PMC article. Review.
Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series.
Gurrieri L, Mercatali L, Ibrahim T, Fausti V, Dall'Agata M, Riva N, Ranallo N, Pasini G, Tazzari M, Foca F, Bartolini D, Riccioni L, Cavatorta C, Morigi FP, Bulgarelli J, Cocchi C, Ghini V, Tosatto L, Martinelli G, Pession A, Ridolfi L. Gurrieri L, et al. Among authors: fausti v. J Neurooncol. 2023 Aug;164(1):55-64. doi: 10.1007/s11060-023-04357-9. Epub 2023 Aug 16. J Neurooncol. 2023. PMID: 37584750 Free PMC article.
Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need.
Vanni S, Fausti V, Fonzi E, Liverani C, Miserocchi G, Spadazzi C, Cocchi C, Calabrese C, Gurrieri L, Riva N, Recine F, Casadei R, Pieri F, Guerrieri AN, Serra M, Ibrahim T, Mercatali L, De Vita A. Vanni S, et al. Among authors: fausti v. Int J Mol Sci. 2023 Apr 8;24(8):6926. doi: 10.3390/ijms24086926. Int J Mol Sci. 2023. PMID: 37108089 Free PMC article.
Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin.
Fausti V, De Vita A, Vanni S, Ghini V, Gurrieri L, Riva N, Casadei R, Maraldi M, Ercolani G, Cavaliere D, Pacilio CA, Pieri F, Foca F, Bongiovanni A, Ranallo N, Calpona S, Frassineti GL, Ibrahim T, Mercatali L. Fausti V, et al. Cancers (Basel). 2023 Feb 8;15(4):1080. doi: 10.3390/cancers15041080. Cancers (Basel). 2023. PMID: 36831421 Free PMC article.
The emerging role of cancer nanotechnology in the panorama of sarcoma.
Mercatali L, Vanni S, Miserocchi G, Liverani C, Spadazzi C, Cocchi C, Calabrese C, Gurrieri L, Fausti V, Riva N, Genovese D, Lucarelli E, Focarete ML, Ibrahim T, Calabrò L, De Vita A. Mercatali L, et al. Among authors: fausti v. Front Bioeng Biotechnol. 2022 Oct 17;10:953555. doi: 10.3389/fbioe.2022.953555. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36324885 Free PMC article. Review.
Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives.
Vanni S, De Vita A, Gurrieri L, Fausti V, Miserocchi G, Spadazzi C, Liverani C, Cocchi C, Calabrese C, Bongiovanni A, Riva N, Mercatali L, Pieri F, Casadei R, Lucarelli E, Ibrahim T. Vanni S, et al. Among authors: fausti v. Ther Adv Med Oncol. 2022 Jun 28;14:17588359221093973. doi: 10.1177/17588359221093973. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35782752 Free PMC article. Review.
54 results